We showed indeed that PSA density, combined with two radiomic features computed on two routinely performed sequences (T2 and ADC), may potentially discriminate clinically significant prostate cancers (Gleason score ≥ 3 + 4). The gene discussed is KLK3; the disease is Familial prostate cancer.